Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

GANXGANX
19 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in GAIN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 453,501 shares of GANX (GAIN THERAPEUTICS INC), worth $921,372 as of 2026-Q2. The position was increased (+1.4% shares).

Current Value

$921,372

Current Shares

453,501

Total Value Change

+$814,372

Total Shares Change

+433,445

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
453,501
+1.4%
$921,3720.0%$2.03
17
2026-Q1
Increased
447,342
+12.4%
$868,5270.0%$2.63
28
2025-Q4
Increased
397,942
+15.6%
$1.3M0.0%$3.05
29
2025-Q3
Increased
344,146
+18.5%
$609,1900.0%$1.81
20
2025-Q2
Increased
290,462
+2.9%
$522,8800.0%$1.97
17
2025-Q1
Increased
282,211
+5.5%
$539,0850.0%$1.89
17
2024-Q4
Decreased
267,421
-1.7%
$577,7010.0%$2.18
0
2024-Q3
Increased
271,972
+48.0%
$484,1570.0%$1.99
23
2024-Q2
Increased
183,736
+3.8%
$235,2170.0%$1.28
16
2024-Q1
Increased
177,091
+16.9%
$667,7340.0%$3.77
28
2023-Q4
Unchanged
151,476
0.0%
$494,6490.0%$3.27
0
2023-Q3
Increased
151,476
+9.2%
$489,3550.0%$3.28
26
2023-Q2
Increased
138,721
+47.3%
$621,4700.0%$4.50
33
2023-Q1
Increased
94,207
+4.5%
$454,0770.0%$4.71
25
2022-Q4
Increased
90,114
+2.4%
$282,0000.0%$3.13
16
2022-Q3
Increased
87,967
+240.7%
$286,0000.0%$3.17
26
2022-Q2
Increased
25,818
+0.7%
$92,0000.0%$3.59
15
2022-Q1
Increased
25,628
+27.8%
$104,0000.0%$4.09
18
2021-Q4
New
20,056
-
$107,0000.0%$5.30
33

Other major holders of GANX: GREENLIGHT CAPITAL INC, Gotham Asset Management, LLC, MARSHALL WACE, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used